Proven Strategies to Accelerate CNS Drug Development

We understand the particular complexities involved with running neurology trials across the spectrum of unique indications.

Our experience ranges from supporting global development planning and submissions for neuroemergency trials, to developing regional recruitment strategies for pediatric epilepsy. We have nearly 200 professionals in-house - all experienced in CNS - to provide the level of support needed for the breadth of neurological disorders such as Alzheimer’s disease, Epilepsy, Multiple Sclerosis, Movement Disorders, Sleep and Stroke.

INC Research has established relationships with a global network of neurologists who have access to large CNS patient populations. As board-certified neurologists, these physicians are dedicated to protecting and treating the brain and nervous system. Many are board certified in movement disorders, neurophysiology, sleep disorders, electrodiagnostic medicine, pain, and pediatrics. Access to this experienced pool of CNS specialists helps us to accelerate patient recruitment and significantly condense enrollment timelines.

Case Studies

Pain: Chronic, Non-Malignant Pain
Pain: Chronic Painful Diabetic Neuropathy
Neurology: Stroke
Psychiatry: Panic Attacks
Psychiatry: Major Depressive Disorder

Leadership

Michael Gibertini, PhD
Executive Vice President, CNS

Thomas Schlagheck, PhD
Vice President, Clinical Development, Global Analgesia

Thomas Zoda, PhD
Senior Vice President, Clinical Development, Neurology and Psychiatry

Biljana Andjelkovic, MD
Vice President, Clinical Operations, Global Analgesia

Warren Prosser, MBA
Vice President, Clinical Operations Global Analgesia

Andrew Silverman, PhD
Vice President, Neurology